Brown & Brown
BRONYSEUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $71.89 Prior regular-session close from the quote source.
- $70.26–$71.52 Regular-session low and high so far today.
- 1.5M Regular-session shares traded · Nov 11, 4:00 PM ET.
- Not yet confirmed The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
- $53.81–$82.58 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own BRO if Brown & Brown converts a decentralized, acquisition-fueled distribution footprint (retail agents + specialty MGUs/wholesale) into recurring commission and fee streams that generate high cash conversion and steady earnings, with acquisitions and specialty/fee mix determining.
BRO price history
Loading recent earnings…
Investment thesis
What must happen next
The decentralized retail + wholesale/MGU distribution model converts policy-level recurring commissions and fees into consistently strong operating cash flow and earnings, sustaining valuation support.StrengtheningMateriality: High
operating_cash_flow increased from $1,010,000,000 (FY2023) to $1,174,000,000 (FY2024) to $1,450,000,000 (FY2025) (fundamentals). If true, investors get predictable cash generation and optionality to fund acquisitions/dividends; if false, earnings and cash will be volatile and the premium multiple is at risk.
Watch: Major carriers materially reduce commission schedules or shift to direct distribution/insurtech platforms, reducing recurring commission flows.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
operating_cash_flow increased from $1,010,000,000 (FY2023) to $1,174,000,000 (FY2024) to $1,450,000,000 (FY2025) (fundamentals).
Open source ↗Growth of the Specialty Distribution segment (programs/MGUs/wholesale) expands higher-margin, fee-based revenue and increases overall profitability and valuation multiple support.HoldingMateriality: High
ITEM 1: Specialty Distribution commissions/fees rose from $1,699M (2023) to $1,985M (2024) to $2,379M (2025), increasing its share of total commissions and fees. If the Specialty/fee mix continues to grow, Brown & Brown can lift margins and justify a premium multiple; if specialty growth stalls or carriers insource MGUs, margin and multiple compress.
Watch: Large insurers or reinsurers expand their direct-to-market MGUs or deploy technology to disintermediate third-party MGUs/wholesale brokers.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
ITEM 1: Specialty Distribution commissions/fees rose from $1,699M (2023) to $1,985M (2024) to $2,379M (2025), increasing its share of total.
Open source ↗Sustaining above-market consolidated revenue CAGR depends on continuing M&A activity and management's ability to fund and integrate acquisitions; without M&A, revenue growth will likely fall back to modest organic rates.HoldingMateriality: Medium
MD&A: the company states historical growth results from focus on new business, customer retention and acquisitions. If M&A continues and integrations succeed, revenue and EPS growth can stay high; if acquisition cadence or funding dries up, headline growth will slow and the stock's growth multiple will be harder to justify.
Watch: A tougher capital market or higher interest rates that increase acquisition financing costs, or management chooses to conserve cash (reducing M&A).
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
MD&A: the company states historical growth results from focus on new business, customer retention and acquisitions.
Open source ↗Profit-sharing contingent commissions and underwriting-related items introduce lumpy, carrier-dependent earnings volatility; margins and cash depend on favorable underwriting results from carrier partners.StrengtheningMateriality: Medium
MD&A: profit-sharing contingent commissions are estimated and accrued and averaged ~4.4% of commissions and fees over the last three years. If contingent commissions remain stable or increase, net income and cash expand; if underwriting deteriorates among carriers, reported earnings and cash receipts can swing negatively, pressuring the valuation.
Watch: A material increase in insurer loss ratios or reinsurance costs reduces profit-sharing payments and causes retroactive adjustments to estimates.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
MD&A: profit-sharing contingent commissions are estimated and accrued and averaged ~4.4% of commissions and fees over the last three years.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
The decentralized retail + wholesale/MGU distribution model converts policy-level recurring commissions and fees into consistently strong operating cash flow and earnings, sustaining valuation support. If true, investors get predictable cash generation and optionality to fund acquisitions/dividends; if false, earnings and cash will be volatile and the premium multiple is at risk.
Growth of the Specialty Distribution segment (programs/MGUs/wholesale) expands higher-margin, fee-based revenue and increases overall profitability and valuation multiple support. If the Specialty/fee mix continues to grow, Brown & Brown can lift margins and justify a premium multiple; if specialty growth stalls or carriers insource MGUs, margin and multiple compress.
Sustaining above-market consolidated revenue CAGR depends on continuing M&A activity and management's ability to fund and integrate acquisitions; without M&A, revenue growth will likely fall back to modest organic rates. If M&A continues and integrations succeed, revenue and EPS growth can stay high; if acquisition cadence or funding dries up, headline growth will slow and the stock's growth multiple will be harder to justify.
Profit-sharing contingent commissions and underwriting-related items introduce lumpy, carrier-dependent earnings volatility; margins and cash depend on favorable underwriting results from carrier partners. If contingent commissions remain stable or increase, net income and cash expand; if underwriting deteriorates among carriers, reported earnings and cash receipts can swing negatively, pressuring the valuation.
All standing thesis claims
Original report summary
Brown & Brown converts a decentralized, acquisition-fueled distribution footprint (retail agents + specialty MGUs/wholesale) into recurring commission and fee streams that generate high cash conversion and steady earnings, with acquisitions and specialty/fee mix determining.
Bull case and bear case
Bull case and bear case for Brown & Brown
Where the evidence on Brown & Brown stands: Holding on the latest evidence (Nov 12, 2026). Of its 4 thesis points, 2 strengthening and 2 holding.
Bull case: what the evidence supports
The decentralized retail + wholesale/MGU distribution model converts policy-level recurring commissions and fees into consistently strong operating cash flow and earnings, sustaining valuation support.
Growth of the Specialty Distribution segment (programs/MGUs/wholesale) expands higher-margin, fee-based revenue and increases overall profitability and valuation multiple support.
Sustaining above-market consolidated revenue CAGR depends on continuing M&A activity and management's ability to fund and integrate acquisitions; without M&A, revenue growth will likely fall back to modest organic rates.
Profit-sharing contingent commissions and underwriting-related items introduce lumpy, carrier-dependent earnings volatility; margins and cash depend on favorable underwriting results from carrier partners.
Bear case: what would count against it
Major carriers materially reduce commission schedules or shift to direct distribution/insurtech platforms, reducing recurring commission flows.
Large insurers or reinsurers expand their direct-to-market MGUs or deploy technology to disintermediate third-party MGUs/wholesale brokers.
A tougher capital market or higher interest rates that increase acquisition financing costs, or management chooses to conserve cash (reducing M&A).
Thesis-Break Engine
Thesis-break watch · Brown & Brown
Loading the break-condition record for Brown & Brown.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedReported results of operations (earnings release).
Brown & Brown filed an SEC 8-K on 2026-10-26: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MixedDirector or principal officer change.
Brown & Brown filed an SEC 8-K on 2026-10-22: Director or principal officer change. It is a dated development that tests the current thesis.
- MixedRegulation FD disclosure.
Brown & Brown filed an SEC 8-K on 2026-09-10: Regulation FD disclosure. It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- Major carriers materially reduce commission schedules or shift to direct distribution/insurtech platforms, reducing recurring commission flows.
- Large insurers or reinsurers expand their direct-to-market MGUs or deploy technology to disintermediate third-party MGUs/wholesale brokers.
- A tougher capital market or higher interest rates that increase acquisition financing costs, or management chooses to conserve cash (reducing M&A).
- A material increase in insurer loss ratios or reinsurance costs reduces profit-sharing payments and causes retroactive adjustments to estimates.
BRO news
Loading headlines…
Financial statements
BRO income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
BRO: quick answers
- Which well-known investors own BRO?
- 1 of the 37 well-known funds tracked here reported BRO shares in their latest 13F filing. By share of the fund's portfolio: Bridgewater Associates (Ray Dalio), 0.0%. Fund portfolios
BRO in well-known investors’ portfolios
1 of 37 funds reported BRO shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.
| Fund | Of its portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| Ray DalioBridgewater Associates | 0.00% | $1.2M | New | Q2 2026 |
